Creo Medical Group (CREO) Insider Trading & Ownership GBX 14.07 -0.56 (-3.79%) As of 12:10 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Creo Medical Group (LON:CREO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.43%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)£921,820.40Number OfInsiders Selling(Last 12 Months)0 Get CREO Insider Trade Alerts Want to know when executives and insiders are buying or selling Creo Medical Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CREO Insider Buying and Selling by Quarter Creo Medical Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/20/2025Christopher Paul HancockInsiderBuy4,712GBX 19£895.281/16/2025Richard John ReesInsiderBuy4,712GBX 19£895.2812/13/2024Kevin CroftonInsiderBuy1,179,000GBX 17£200,43010/24/2024Richard John ReesInsiderBuy98,000GBX 20£19,60010/21/2024Kevin CroftonInsiderBuy2,916,666GBX 24£699,999.84 (Data available from 1/1/2013 forward) CREO Insider Trading Activity - Frequently Asked Questions Who is on Creo Medical Group's Insider Roster? The list of insiders at Creo Medical Group includes Charles Spicer, Christopher Paul Hancock, Craig Jonathan Gulliford, Kevin Crofton, and Richard John Rees. Learn more on insiders at CREO. What percentage of Creo Medical Group stock is owned by insiders? 22.43% of Creo Medical Group stock is owned by insiders. Learn more on CREO's insider holdings. Which Creo Medical Group insiders have been buying company stock? The following insiders have purchased CREO shares in the last 24 months: Christopher Paul Hancock (£895.28), Kevin Crofton (£900,429.84), and Richard John Rees (£20,495.28). How much insider buying is happening at Creo Medical Group? Insiders have purchased a total of 4,203,090 CREO shares in the last 24 months for a total of £921,820.40 bought. Creo Medical Group Key ExecutivesMr. Craig Jonathan Gulliford (Age 54)CEO & Executive Director Compensation: $472.66kProf. Christopher Paul Hancock (Age 57)Founder, CTO & Executive Director Compensation: $360.17k1 recent tradesMr. Richard John Rees ACA (Age 48)CFO, Company Secretary & Executive Director Compensation: $359.8k2 recent tradesMr. David Gerard Woods (Age 59)Chief Commercial Officer & Executive Director Compensation: $446.38kMr. Phil HalesSales & Marketing Director More Insider Trading Tools from MarketBeat Related Companies EKF Diagnostics Insider Trading Novacyt Insider Trading Inspiration Healthcare Group Insider Trading NIOX Group Insider Trading Smith & Nephew Insider Trading MaxCyte Insider Trading Tristel Insider Trading Bioventix Insider Trading 4basebio Insider Trading Diaceutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (LON:CREO) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
